These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19854463)

  • 21. Reduction of pharmaceutically active compounds by a lagoon wetland wastewater treatment system in Southeast Louisiana.
    Conkle JL; White JR; Metcalfe CD
    Chemosphere; 2008 Dec; 73(11):1741-8. PubMed ID: 18977010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies.
    Ying GG; Kookana RS; Kolpin DW
    J Environ Monit; 2009 Aug; 11(8):1498-505. PubMed ID: 19657534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic modelling of nitrification in an aerated facultative lagoon.
    Houweling D; Kharoune L; Escalas A; Comeau Y
    Water Res; 2008 Jan; 42(1-2):424-32. PubMed ID: 17689585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater.
    Kreuzinger N; Clara M; Strenn B; Kroiss H
    Water Sci Technol; 2004; 50(5):149-56. PubMed ID: 15497842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A broad spectrum analytical scheme for the screening of endocrine disruptors (EDs), pharmaceuticals and personal care products in wastewaters and natural waters.
    Bruchet A; Prompsy C; Fillppi G; Souall A
    Water Sci Technol; 2002; 46(3):97-104. PubMed ID: 12227610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probabilistic application of a fugacity model to predict triclosan fate during wastewater treatment.
    Bock M; Lyndall J; Barber T; Fuchsman P; Perruchon E; Capdevielle M
    Integr Environ Assess Manag; 2010 Jul; 6(3):393-404. PubMed ID: 20821703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
    Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
    Environ Pollut; 2009 May; 157(5):1721-6. PubMed ID: 19201071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation on the behaviour of selected pharmaceuticals in the groundwater after infiltration of treated wastewater.
    Kreuzinger N; Clara M; Strenn B; Vogel B
    Water Sci Technol; 2004; 50(2):221-8. PubMed ID: 15344795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of acidic pharmaceuticals and potential endocrine disrupting compounds in wastewaters and spring waters by selective elution and analysis by gas chromatography-mass spectrometry.
    Gibson R; Becerril-Bravo E; Silva-Castro V; Jiménez B
    J Chromatogr A; 2007 Oct; 1169(1-2):31-9. PubMed ID: 17884063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of biodegradable dissolved organic carbon (BDOC) to assess the potential for transformation of wastewater-derived contaminants in surface waters.
    Lim MH; Snyder SA; Sedlak DL
    Water Res; 2008 Jun; 42(12):2943-52. PubMed ID: 18423515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Removal of pharmaceuticals and fragrances in biological wastewater treatment.
    Joss A; Keller E; Alder AC; Göbel A; McArdell CS; Ternes T; Siegrist H
    Water Res; 2005 Sep; 39(14):3139-52. PubMed ID: 16043210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works.
    Thomas KV; Dye C; Schlabach M; Langford KH
    J Environ Monit; 2007 Dec; 9(12):1410-8. PubMed ID: 18049781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polar organic chemical integrative sampler (POCIS): application for monitoring organic micropollutants in wastewater effluent and surface water.
    Miège C; Budzinski H; Jacquet R; Soulier C; Pelte T; Coquery M
    J Environ Monit; 2012 Feb; 14(2):626-35. PubMed ID: 22193508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation.
    Rosal R; Rodríguez A; Perdigón-Melón JA; Petre A; García-Calvo E; Gómez MJ; Agüera A; Fernández-Alba AR
    Water Res; 2010 Jan; 44(2):578-88. PubMed ID: 19628245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants.
    Clara M; Kreuzinger N; Strenn B; Gans O; Kroiss H
    Water Res; 2005 Jan; 39(1):97-106. PubMed ID: 15607169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elimination of pharmaceuticals in sewage treatment plants in Finland.
    Vieno N; Tuhkanen T; Kronberg L
    Water Res; 2007 Mar; 41(5):1001-12. PubMed ID: 17261324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effluent from drug manufactures contains extremely high levels of pharmaceuticals.
    Larsson DG; de Pedro C; Paxeus N
    J Hazard Mater; 2007 Sep; 148(3):751-5. PubMed ID: 17706342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of fluoroquinolone antibiotics in wastewater effluents by liquid chromatography-mass spectrometry and fluorescence detection.
    Nakata H; Kannan K; Jones PD; Giesy JP
    Chemosphere; 2005 Feb; 58(6):759-66. PubMed ID: 15621189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain).
    Santos JL; Aparicio I; Callejón M; Alonso E
    J Hazard Mater; 2009 May; 164(2-3):1509-16. PubMed ID: 18990491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant.
    Stackelberg PE; Furlong ET; Meyer MT; Zaugg SD; Henderson AK; Reissman DB
    Sci Total Environ; 2004 Aug; 329(1-3):99-113. PubMed ID: 15262161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.